HIV感染相关性非硬化性门脉高压症研究进展
被引量:1
摘要
人类免疫缺陷病毒(HIV)感染相关性非硬化性门脉高压(NCPH)是一种与HIV感染及治疗相关,以反复消化道出血、脾大为主要临床表现的疾病。2006年Maida首次对本病进行了报道。本病因临床表现及辅助检查缺乏特异性,容易被误诊及漏诊。本综述报道了近几年HIV感染相关性NCPH的最新研究进展,为进一步研究本病提供新的思路。
出处
《肝脏》
2012年第7期518-520,共3页
Chinese Hepatology
参考文献21
-
1Maida I, Nflfiunez M, Rios M J, et al. Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquit Immune Defic Syndr, 2006,42 : 177-182.
-
2Mallet V, Blanchard P, Verkarre V, et al. Nodular regenerativehyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS, 2007,21 : 187-192.
-
3Maida I, Garcia-Gasco P, Sotgiu G, et al. Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome. Antivir Ther, 2008,13 .. 103-107.
-
4US Food and Drug Administration. FDA drug safety communication: serious liver disorder associated with the use of Videx/Videx EC(didanosine) Available at: http://www, fda. gov/ Drugs/DrugSafety/Post market Drug Safety Information for Patient sand Providers/ucm199:69.
-
5htm. Vispo E, Morello J, Rodriguez-Novoa S, et al. Noncirrhotic portal hypertension in HIV infection. Curr Opin Infect Dis, 201l, 24 : 12- 18.
-
6Cachay ER, Peterson MR, Goicoeehea M, et al. Didanosine Exposure and Noncirrhotic Portal Hypertension in a HIV Clinic in North America: a Follow-up Study. Br J Med Res, 2011,1 : 346- 355.
-
7Kovari H, Ledergerber B, Peter U, et al. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine; a nested case-control study. Clin Infect Dis, 2009,49:626-635.
-
8Brenehley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med, 2006,12 :1365-1371.
-
9Jerala R. Structural biology of the LPS recognition. Int J Med Mierobiol, 2007,297 : 353-363.
-
10Creagh EM, O'Neill LAJ. TLRs, NLRs and RLRs; a trinity of pathogen sensors that cooperate in innate immunity. Trends Immunol, 2006,27 : 352-357.
二级参考文献11
-
1Ohnishi K, Saito M, Sato S, et al. Portal hemodynamics in idiopathic portal hypertension (Banti's syndrome). Comparison with chronic persistent hepatitis and normal subjects. Gastroenterology,1987, 92: 751-758.
-
2Okuda K, Ohnishi K, Kimura K, et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients.Gastroenterology, 1985, 89: 279-286.
-
3Nakanuma Y, Tsuneyama K, Ohbu M, et al. Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract, 2001, 197: 65-76.
-
4Okudaira M, Ohbu M, Okuda K. Idiopathic portal hypertension and its pathology. Semin Liver Dis, 2002, 22: 59-72.
-
5Nakanuma Y, Hoso M, Sasaki M, et al. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology.Histopathology, 1996, 28: 195-204.
-
6Nakanuma Y, Nonomura A, Hayashi M, et al. Pathology of the liver in "idiopathic portal hypertension" associated with autoimmune disease. The Ministry of Health and Welfare Disorders of Portal Circulation Research Committee. Acta Pathol Jpn, 1989, 39: 586-592.
-
7Okuda K, Nakashima T, Okudaira M, et al. Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study.Liver, 1982, 2: 176-192.
-
8Takagi K, Nishio S, Akimoto K, et al. A case of systemic sclerosis complicated by idiopathic portal hypertension: case report and literature review. Mod Rheumatol, 2006, 16: 183-187.
-
9Tsuneyama K, Harada K, Katayanagi K, et al. Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a review of literature. J Gastroenterol Hepatol, 2002, 17: 217-223.
-
10Tsuneyama K, Kouda W, Nakanuma Y. Portal and parenchymal alterations of the liver in idiopathic portal hypertension: a histological and irnmunochemical study. Pathol Res Pract, 2002, 198: 597-603.
共引文献11
-
1强春倩,林志光,郭砚梅.特发性门静脉高压症合并HBV感染1例[J].中国现代医生,2009,47(29):116-117.
-
2郭涛,钱家鸣,朱丽明,周炜洵,朱峰,孙刚,方秀才.对肝结节状再生性增生的再认识—附18例临床分析[J].胃肠病学和肝病学杂志,2010,19(4):326-329. 被引量:3
-
3王征,蒋楹,杨重庆,刘冬戈.慢性砷中毒引起特发性门静脉高压一例[J].中华病理学杂志,2012,41(7):487-488. 被引量:1
-
4朱洪芳,吴广利,刘成霞,牛琼,马锋振,史宁,李锟,王伟.48例疑难肝病临床与病理分析[J].肝脏,2014,19(4):241-245. 被引量:1
-
5张亦瑾,高学松,段雪飞.特发性门静脉高压症10例临床分析[J].中华全科医师杂志,2015,14(8):611-615. 被引量:3
-
6吕成娇,丁玉平,牛海艳,杨梅,李海.特发性门静脉高压1例3年随访报道及文献综述[J].肝脏,2017,22(11):1047-1049. 被引量:2
-
7罗文萍,马红,赵新颜.肝血管病的病理学特征及鉴别诊断要点[J].临床肝胆病杂志,2018,34(11):2289-2294. 被引量:5
-
8朱芳,张振江,袁玲,裴兵.慢性乙型肝炎合并特发性门静脉高压症1例报告[J].临床肝胆病杂志,2021,37(6):1416-1418. 被引量:2
-
9杨华夏.系统性红斑狼疮的胃肠道损伤[J].中国实用内科杂志,2021,41(9):753-756. 被引量:3
-
10张玉姣,邵晨,雷金艳,王秀红,任媛媛,马安林.特发性非硬化性门脉高压115例临床与病理特征分析[J].实用医学杂志,2022,38(18):2324-2330. 被引量:2
同被引文献6
-
1刘霞,王泰龄,项灿宏,彭向欣,王跃,陈念,张敏.特发性门静脉高压的肝脏病理学分析[J].中华肝脏病杂志,2007,15(5):374-377. 被引量:12
-
2刘英辉,尹洪竹,陈立娟.特发性非硬化性门脉高压症6例报告[J].临床肝胆病杂志,2008,24(1):78-78. 被引量:3
-
3郑瑞丹,陈雪婉,郎振为,蒋瓅.非活动性HBsAg携带者并特发性门静脉高压症1例[J].中华肝脏病杂志,2010,18(4):311-311. 被引量:3
-
4陈晓通,严爱武.特发性非硬化性门脉高压症9例报告[J].腹部外科,1999,12(2):70-71. 被引量:2
-
5刘召波,卢实春,李宁.特发性门静脉高压症3例[J].中华肝脏病杂志,2011,19(8):628-629. 被引量:2
-
6周颖,周力,陈晓琴.非肝硬化性门脉高压症52例病因分析[J].贵阳医学院学报,2013,38(1):97-98. 被引量:1
二级引证文献2
-
1唐郑一,张倩,邵雪,金珍婧,杨岚岚.特发性门静脉高压症1例报道并文献回顾[J].肝脏,2019,24(12):1484-1486.
-
2李如月,丁玉平,向晓辉,李海.特发性门静脉高压4年并发小肠毛细血管出血1例及文献复习[J].中国肝脏病杂志(电子版),2020,12(1):84-88.
-
1赵华维,徐大毅.非肝硬化性肝脏结节性过度增生[J].临床肝胆病杂志,1989,5(4):195-196.
-
2杜虎.内镜治疗Dieulafoy病12例临床分析[J].中国当代医药,2010,17(7):172-172. 被引量:2
-
3丁凤亚.Meckel憩室致反复消化道出血3例[J].解剖与临床,1997,2(3):112-112.
-
4陈跃.肝硬化的早期发现[J].健康博览,2010(1):15-15.
-
5安子元.非硬化性门脉纤维化[J].胃肠病学和肝病学杂志,1995,4(3):228-231.
-
6刘英辉,尹洪竹,陈立娟.特发性非硬化性门脉高压症6例报告[J].临床肝胆病杂志,2008,24(1):78-78. 被引量:3
-
7谢兵,邱梦琦,孟淑云.回盲部静脉曲张致反复消化道出血一例[J].中华消化内镜杂志,2007,24(3):201-201.
-
8黄曜勇,杨发文,朱广明,黄远霞.特发性非硬化性脾-门静脉高压综合征1例的诊断分析[J].临床医学研究与实践,2016,1(23):72-72.
-
9范里.伴反复消化道出血的小肠间质瘤1例[J].胃肠病学,2011,16(1):63-64.
-
10余祥奎,王晓霖.慢性丙型肝炎远期随访[J].实用肝脏病杂志,2003,6(2):85-86.